Company Performance: Brooklyn ImmunoTherapeutics' clinical trial results, FDA approvals, and overall progress in developing gene and cell therapies heavily influence stock price. Positive developments generally increase the price, while setbacks decrease it.

Market Conditions: Broader market trends, especially in the biotechnology sector, affect BKKLY's stock. Bull markets tend to lift all stocks, while bear markets can drag them down. Investor sentiment also plays a significant role.

Financial Health: Brooklyn ImmunoTherapeutics' cash reserves, burn rate, and ability to secure funding impact investor confidence. Strong financial footing is viewed favorably, while concerns about solvency can negatively affect the stock.

News and Events: Major news announcements, such as partnerships, acquisitions, or regulatory decisions, can trigger significant price swings in BKKLY.US stock. These events often create both opportunities and risks for investors.

Competition: The competitive landscape in gene and cell therapy influences BKKLY.US's prospects. The success of competitors or the emergence of new therapies can impact market share and investor perception.

Management Team: The experience and reputation of Brooklyn ImmunoTherapeutics' management team are critical. A strong leadership team inspires confidence, while concerns about management competence can negatively affect the stock price.